The Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) has an implied analyst target price of $105.45 per unit, indicating a potential upside of 57.51% from its recent trading price of $66.95. This analysis is based on the ETF’s underlying holdings.
Key holdings contributing to this outlook include IDEAYA Biosciences Inc (IDYA), with a potential upside of 122.36% from a recent price of $22.97 to an average target of $51.08; Denali Therapeutics Inc (DNLI), expected to rise 116.89% from $15.00 to $32.53; and Replimune Group Inc (REPL), which could increase by 110.54% from $10.39 to a target of $21.88.
| Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
|---|---|---|---|---|
| Direxion Daily S&P Biotech Bull 3X Shares ETF | LABU | $66.95 | $105.45 | 57.51% |
| IDEAYA Biosciences Inc | IDYA | $22.97 | $51.08 | 122.36% |
| Denali Therapeutics Inc | DNLI | $15.00 | $32.53 | 116.89% |
| Replimune Group Inc | REPL | $10.39 | $21.88 | 110.54% |
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
